Cancer is found through a combination of physical exams, imaging scans, blood tests, and biopsies, with the specific path depending on whether doctors are screening a healthy person or investigating symptoms. No single test can confirm cancer on its own. In most cases, the process moves from an initial clue (a lump, an abnormal scan, a suspicious blood result) to increasingly targeted tests, ending with a biopsy that examines cells under a microscope.
Screening vs. Investigating Symptoms
There are two broad entry points into cancer diagnosis. Screening uses simple tests across healthy populations to catch cancer before symptoms appear. It works well for a limited set of cancers: breast, cervical, and colorectal cancers are the main types screened for, and together they account for about 28% of cancer cases in the WHO European Region. If you’ve had a routine mammogram, Pap smear, or colonoscopy, that was screening.
The other path starts when something feels wrong. A new lump, unexplained weight loss, persistent pain, blood in your stool, or a cough that won’t go away. Early diagnosis programs focus on shortening the gap between first symptoms and treatment. For a healthy person with clear symptoms, the median time from the first sign to a confirmed diagnosis is about 11 days. That timeline stretches significantly for people managing multiple other health conditions, sometimes taking five to six times longer.
What Happens During a Physical Exam
The first step is often a hands-on examination. A doctor checks for lumps, swelling, skin changes, or anything unusual in the area where symptoms are occurring. They’ll feel for the size of any mass, whether it moves freely or seems attached to surrounding tissue, and whether nearby lymph nodes are enlarged. Swollen lymph nodes are a common early clue, particularly the ones in the armpit (for breast concerns) and the neck (for head and neck cancers).
For suspected gastrointestinal cancers, the exam includes pressing on the abdomen and liver area. Men with prostate concerns get a digital rectal exam. Head and neck evaluations involve inspecting the nasal cavity, mouth, and throat surfaces, along with feeling the tissues from both inside and outside the mouth. A physical exam alone can’t diagnose cancer, but it tells doctors where to look next and which tests to order.
Imaging: Seeing Inside the Body
Imaging scans let doctors see tumors without surgery. The type of scan depends on where the suspected cancer is and what information is needed.
- CT scans take X-ray images from many angles, then a computer assembles them into a detailed 3D picture. They’re good at showing the size, shape, and location of a tumor.
- MRI scans use magnets and radio waves instead of radiation. They produce especially detailed images of soft tissues like the brain, spinal cord, and muscles.
- Ultrasound uses sound waves to create real-time images. It’s often the first imaging test for lumps in the breast, thyroid, or abdomen because it’s quick, widely available, and involves no radiation.
- PET scans work differently from the others. Instead of showing structure, they show metabolic activity. You receive a small amount of a radioactive sugar beforehand. Cancer cells, which burn energy faster than normal cells, absorb more of it and light up on the scan.
Doctors increasingly use PET and CT scans together in a single session. The CT reveals the anatomy, the PET reveals which cells are behaving abnormally, and the combination produces a more detailed picture than either test alone. This is particularly useful for determining whether cancer has spread to other parts of the body.
Blood Tests and Tumor Markers
Blood tests can raise suspicion of cancer, but they rarely confirm it by themselves. Certain cancers release proteins or other substances into the bloodstream called tumor markers. Some of the most commonly tested include PSA for prostate cancer, CA-125 for ovarian cancer, and alpha-fetoprotein (AFP) for liver cancer and certain germ cell tumors.
The limitation is that tumor markers aren’t perfectly reliable for diagnosis. PSA levels, for instance, can rise from non-cancerous prostate enlargement. CA-125 can be elevated by endometriosis or even menstruation. These markers are more consistently useful for tracking whether a known cancer is responding to treatment or coming back after remission. A complete blood count can also flag blood cancers like leukemia by revealing abnormal numbers or types of blood cells.
Biopsy: The Definitive Test
A biopsy is the only way to confirm cancer. It involves removing a sample of suspicious tissue so a pathologist can examine the cells under a microscope. The method used depends on where the suspected cancer is located and how accessible it is.
Needle biopsies are the most common starting point. If a doctor can feel a lump through the skin, like in the breast or a lymph node, they may use a fine needle to draw out a small sample of fluid and cells. A core needle biopsy uses a slightly larger needle with a cutting tip to extract a small column of tissue, which gives the pathologist more material to work with. When the suspicious area can’t be felt from the outside, doctors guide the needle using ultrasound or CT imaging to reach spots deep in the liver, lung, or prostate.
Endoscopic biopsies use a thin, flexible tube with a camera to reach internal surfaces. The tube can go through the mouth to examine the stomach or esophagus, through the rectum for the colon, or through the urinary tract for bladder concerns. When the doctor spots something abnormal on camera, they can snip a tiny tissue sample through the same tube.
Skin biopsies range from a simple surface scrape (shave biopsy) to removing an entire suspicious mole or lesion (excisional biopsy). The choice depends on how deep the abnormal cells are thought to extend. Bone marrow biopsies, taken from the hip bone, are used to diagnose blood cancers like leukemia, lymphoma, and multiple myeloma, or to check whether a cancer that started elsewhere has reached the marrow.
Surgical biopsies are reserved for situations where other methods can’t reach the tissue or when earlier biopsy results were inconclusive. A surgeon may remove part of the suspicious area or all of it, depending on the situation.
Genetic Testing and Cancer Risk
Genetic testing plays two distinct roles in finding cancer. The first is identifying inherited risk. Some people carry gene mutations present in every cell of their body from birth. These inherited variants, in genes like BRCA1 and BRCA2, underlie conditions like hereditary breast and ovarian cancer syndrome or Lynch syndrome, which increases colorectal cancer risk. If you have a strong family history of cancer, genetic testing can reveal whether you carry one of these mutations so you and your doctor can plan more aggressive screening.
The second role involves testing the tumor itself. Most cancers arise from mutations that accumulate in a specific tissue over a person’s lifetime. These acquired mutations aren’t inherited and aren’t present in the rest of the body. When a tumor is biopsied, doctors can analyze its DNA to understand what’s driving its growth. This information doesn’t just confirm the diagnosis. It can determine which treatments are most likely to work against that particular tumor’s biology.
False Alarms Are Common
An abnormal screening result does not mean you have cancer. In the United States, about 10% of mammograms result in a callback for further testing. Of those callbacks, only about 7% ultimately lead to a cancer diagnosis. That means the vast majority of women called back after a mammogram get good news, but the anxiety of waiting for follow-up results is real. Similar patterns exist with other screening tests. An elevated PSA level triggers further investigation in many men who turn out not to have prostate cancer.
This is exactly why the diagnostic process involves multiple steps. Each test narrows the possibilities. A physical exam raises a question. Imaging helps locate and characterize the concern. Blood tests add context. And a biopsy provides the definitive answer. The process can feel slow when you’re the one waiting, but each layer exists to avoid both missed cancers and unnecessary treatment.
How AI Is Changing Detection
Artificial intelligence is increasingly being used to help radiologists spot cancers on imaging scans. A hybrid AI model called C-Swin, tested on lung CT scans, achieved 96.26% accuracy in identifying lung cancer, a 2 to 7 percentage point improvement over previous methods. Its balanced performance meant it was good at catching real cancers without frequently flagging healthy tissue as suspicious.
AI doesn’t replace the diagnostic process. It functions as a second set of eyes, flagging areas on a scan that a human reviewer should examine more closely. This is especially valuable in high-volume settings like breast cancer screening programs, where radiologists read hundreds of mammograms per day and subtle abnormalities can be easy to miss.